Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2599)
All Articles published online
|
Jan 14, 2007 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Colecchia A, Vestito A, Pasqui F, Mazzella G, Roda E, Pistoia F, Brandimarte G, Festi D. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World J Gastroenterol 2007; 13(2): 264-269 [PMID: 17226906 DOI: 10.3748/wjg.v13.i2.264] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i2/264.htm |
| Number | Citing Articles |
| 1 |
Therapie–Handbuch Innere Medizin Sonderedition 2011⁄2012. 2011; : 359 doi: 10.1016/B978-3-437-22702-8.50009-1
|
| 2 |
Rebecca E. Burgell, Jane G. Muir, Peter R. Gibson. Pathogenesis of Colonic Diverticulosis: Repainting the Picture. Clinical Gastroenterology and Hepatology 2013; 11(12): 1628 doi: 10.1016/j.cgh.2013.08.046
|
| 3 |
Samar Ojaima, Tony Korman. Kucers' The Use of Antibiotics Sixth Edition. 2010; : 1637 doi: 10.1201/b13787-130
|
| 4 |
Hoonmo L Koo, Herbert L DuPont. Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Current Opinion in Gastroenterology 2010; 26(1): 17 doi: 10.1097/MOG.0b013e328333dc8d
|
| 5 |
Adi Lahat, Daniela Necula, Miri Yavzori, Orit Picard, Sharon Halperin, Rami Eliakim, Shomron Ben-Horin. Prolonged Recurrent Abdominal Pain is Associated With Ongoing Underlying Mucosal Inflammation in Patients who had an Episode of Acute Complicated Diverticulitis. Journal of Clinical Gastroenterology 2019; 53(5): e178 doi: 10.1097/MCG.0000000000000980
|
| 6 |
Sasan Mosadeghi, Taft Bhuket, Neil Stollman. Diverticular disease. Current Opinion in Gastroenterology 2015; 31(1): 50 doi: 10.1097/MOG.0000000000000145
|
| 7 |
Herbert L DuPont. Biologic properties and clinical uses of rifaximin. Expert Opinion on Pharmacotherapy 2011; 12(2): 293 doi: 10.1517/14656566.2011.546347
|
| 8 |
Veronica Ojetti, Ernesto Cristiano Lauritano, Federico Barbaro, Alessio Migneco, Maria Elena Ainora, Luigi Fontana, Maurizio Gabrielli, Antonio Gasbarrini. Rifaximin pharmacology and clinical implications. Expert Opinion on Drug Metabolism & Toxicology 2009; 5(6): 675 doi: 10.1517/17425250902973695
|
| 9 |
Johann Dréanic, Elena Sion, Marion Dhooge, Bertrand Dousset, Marine Camus, Stanislas Chaussade, Romain Coriat. Traitement de la diverticulite aiguë sigmoïdienne : revue de la littérature. La Presse Médicale 2015; 44(11): 1113 doi: 10.1016/j.lpm.2015.08.004
|
| 10 |
Antonio Tursi, Marcello Picchio, Walter Elisei, Francesco Di Mario, Carmelo Scarpignato, Giovanni Brandimarte. Management of Patients With Diverticulosis and Diverticular Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 1): S101 doi: 10.1097/MCG.0000000000000654
|
| 11 |
Julius Špičák, Miloš Kučera, Gabriela Suchánková. Diverticular disease: diagnosis and treatment. Vnitřní lékařství 2018; 64(6): 621 doi: 10.36290/vnl.2018.086
|
| 12 |
V. Ojetti, G. Gigante, M.E. Ainora, F. Fiore, F. Barbaro, A. Gasbarrini. Microflora imbalance and gastrointestinal diseases. Digestive and Liver Disease Supplements 2009; 3(2): 35 doi: 10.1016/S1594-5804(09)60017-6
|
| 13 |
Edith Lahner, Bruno Annibale. Probiotics, Prebiotics, and Synbiotics. 2016; : 501 doi: 10.1016/B978-0-12-802189-7.00035-6
|
| 14 |
Antonio Tursi. Diverticular disease: A therapeutic overview. World Journal of Gastrointestinal Pharmacology and Therapeutics 2010; 1(1): 27-35 doi: 10.4292/wjgpt.v1.i1.27
|
| 15 |
Melanie Jane Maslow, Cynthia Portal-Celhay. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2015; : 339 doi: 10.1016/B978-1-4557-4801-3.00027-8
|
| 16 |
E. V. Golovanova. Cyclic rifaximin and soluble dietary fiber therapy for symptomatic diverticular disease: effective prevention of complications. Medical Council 2019; (3): 98 doi: 10.21518/2079-701X-2019-3-98-107
|
| 17 |
Jasmohan S. Bajaj, Giovanni Barbara, Herbert L. DuPont, F. Mearin, Antonio Gasbarrini, Jan Tack. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Digestive and Liver Disease 2018; 50(8): 741 doi: 10.1016/j.dld.2018.04.020
|
| 18 |
Giovanni Maconi, Giovanni Barbara, Cristina Bosetti, Rosario Cuomo, Bruno Annibale. Treatment of Diverticular Disease of the Colon and Prevention of Acute Diverticulitis: A Systematic Review. Diseases of the Colon & Rectum 2011; 54(10): 1326 doi: 10.1097/DCR.0b013e318223cb2b
|
| 19 |
László Lakatos, Péter László Lakatos. Colonic diverticular: disease diagnosis and therapy. Orvosi Hetilap 2012; 153(6): 205 doi: 10.1556/OH.2012.29311
|
| 20 |
M. M. SZOJDA, M. A. CUESTA, C. M. MULDER, R. J. F. FELT‐BERSMA. Review article: management of diverticulitis. Alimentary Pharmacology & Therapeutics 2007; 26(s2): 67 doi: 10.1111/j.1365-2036.2007.03491.x
|
| 21 |
Carmelo Scarpignato, Neil Stollman. Colonic Diverticular Disease. 2022; : 209 doi: 10.1007/978-3-030-93761-4_18
|
| 22 |
Earl R. Gonzales, Karim Alavi. Evaluation and Treatment of Uncomplicated Diverticular Disease. Seminars in Colon and Rectal Surgery 2011; 22(3): 162 doi: 10.1053/j.scrs.2011.05.005
|
| 23 |
Sylvia Stallinger, Norbert Eller, Christoph Högenauer. Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease. Wiener klinische Wochenschrift 2014; 126(1-2): 9 doi: 10.1007/s00508-013-0447-7
|
| 24 |
Marilia Carabotti, Bruno Annibale, Carola Severi, Edith Lahner. Role of Fiber in Symptomatic Uncomplicated Diverticular Disease: A Systematic Review. Nutrients 2017; 9(2): 161 doi: 10.3390/nu9020161
|
| 25 |
Johann Dréanic, Elena Sion, Marion Dhooge, Bertrand Dousset, Marine Camus, Stanislas Chaussade, Romain Coriat. Traitement de la diverticulite aiguë sigmoïdienne : revue de la littérature. Journal Européen des Urgences et de Réanimation 2016; 28(1): 26 doi: 10.1016/j.jeurea.2016.02.003
|
| 26 |
Anna Pietrzak, Grażyna Rydzewska, Katarzyna Neubauer, Tomasz Banasiewicz, Wiesław Tarnowski. One-year cyclic therapy with rifaximin-α is effective in the treatment of SUDD (Symptomatic Uncomplicated Diverticular Disease) also in patients with a history of complicated diverticulitis. Polish Journal of Surgery 2023; 95(4): 54 doi: 10.5604/01.3001.0053.8079
|
| 27 |
David J. Humes, Robin C. Spiller. Yamada' s Textbook of Gastroenterology. 2015; : 1522 doi: 10.1002/9781118512074.ch76
|
| 28 |
Marie-Louise Dichman, Steffen Jais Rosenstock, Daniel M Shabanzadeh. Antibiotics for uncomplicated diverticulitis. Cochrane Database of Systematic Reviews 2022; 2022(6) doi: 10.1002/14651858.CD009092.pub3
|
| 29 |
Neil Stollman, Simon Magowan, Fergus Shanahan, Eamonn M.M. Quigley. A Randomized Controlled Study of Mesalamine After Acute Diverticulitis. Journal of Clinical Gastroenterology 2013; 47(7): 621 doi: 10.1097/MCG.0b013e31828003f6
|
| 30 |
Guy W. Neff, Michael Jones, Taylor Broda, Mark Jonas, Ravinuthala Ravi, David Novick, Tiffany E. Kaiser, Nyingi Kemmer. Durability of Rifaximin Response in Hepatic Encephalopathy. Journal of Clinical Gastroenterology 2012; 46(2): 168 doi: 10.1097/MCG.0b013e318231faae
|
| 31 |
L. Daniels, A. E. Budding, N. de Korte, A. Eck, J. A. Bogaards, H. B. Stockmann, E. C. Consten, P. H. Savelkoul, M. A. Boermeester. Fecal microbiome analysis as a diagnostic test for diverticulitis. European Journal of Clinical Microbiology & Infectious Diseases 2014; 33(11): 1927 doi: 10.1007/s10096-014-2162-3
|
| 32 |
Lisa L. Strate, Anne F. Peery, Ignacio Neumann. American Gastroenterological Association Institute Technical Review on the Management of Acute Diverticulitis. Gastroenterology 2015; 149(7): 1950 doi: 10.1053/j.gastro.2015.10.001
|
| 33 |
N. V. Orlova, D. V. Lukanin. Diverticular disease of colon. Unresolved issues. Medical alphabet 2019; 2(27): 26 doi: 10.33667/2078-5631-2019-2-27(402)-26-31
|
| 34 |
Mariam N. Hantouli, David J. Droullard, Lisa L. Strate, David R. Flum, Erika M. Wolff, Mukta K. Krane, Diana K.N. Louden, Giana H. Davidson. Optimizing medical management for diverticular disease: A systematic review and gap analysis. Seminars in Colon and Rectal Surgery 2020; 31(4): 100782 doi: 10.1016/j.scrs.2020.100782
|
| 35 |
Eleonora Scaioli, Antonio Colecchia, Giovanni Marasco, Ramona Schiumerini, Davide Festi. Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon. Digestive Diseases and Sciences 2016; 61(3): 673 doi: 10.1007/s10620-015-3925-0
|
| 36 |
Lukasz Krokowicz, Zoran Stojcev, Bartosz Filip Kaczmarek, Wojciech Kociemba, Elżbieta Kaczmarek, Jaroslaw Walkowiak, Piotr Krokowicz, Michal Drews, Tomasz Banasiewicz. Microencapsulated sodium butyrate administered to patients with diverticulosis decreases incidence of diverticulitis—a prospective randomized study. International Journal of Colorectal Disease 2014; 29(3): 387 doi: 10.1007/s00384-013-1807-5
|
| 37 |
Loai Albarqouni, Yousuf El Mokhallalati, Mohammad JH Elhissi, Said Alyacoubi, Sobhi Skaik, Khamis Elessi, Rahul Kumar, Balendra P Singh, Vijay Kumar. Prophylactic antibiotics for preventing recurrent symptomatic episodes of acute diverticulitis. Cochrane Database of Systematic Reviews 2013; doi: 10.1002/14651858.CD010635
|
| 38 |
Wen Boynton, Martin Floch. New strategies for the management of diverticular disease: insights for the clinician. Therapeutic Advances in Gastroenterology 2013; 6(3): 205 doi: 10.1177/1756283X13478679
|
| 39 |
Timothy J. Ness, L. Vandy Black. Evidence‐Based Chronic Pain Management. 2010; : 174 doi: 10.1002/9781444314380.ch15
|
| 40 |
A. Tursi, A. Papa, S. Danese. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon. Alimentary Pharmacology & Therapeutics 2015; 42(6): 664 doi: 10.1111/apt.13322
|
| 41 |
Chirag D. Trivedi, Kiron M. Das. Emerging Therapies for Diverticular Disease of the Colon. Journal of Clinical Gastroenterology 2008; 42(10): 1145 doi: 10.1097/MCG.0b013e318188adc1
|
| 42 |
Davide Festi, Antonio Colecchia. Mesalazine and Rifaximin in Symptomatic Uncomplicated Diverticular Disease. The American Journal of Gastroenterology 2009; 104(2): 532 doi: 10.1038/ajg.2008.53
|
| 43 |
A. TURSI, S. PAPAGRIGORIADIS. Review article: the current and evolving treatment of colonic diverticular disease. Alimentary Pharmacology & Therapeutics 2009; 30(6): 532 doi: 10.1111/j.1365-2036.2009.04072.x
|
| 44 |
A. Colecchia, D. Festi, E. Scaioli, V. Ruggiero, M. Berardino, P. Portincasa. Bacterial flora, gas and antibiotics. Digestive and Liver Disease Supplements 2009; 3(2): 54 doi: 10.1016/S1594-5804(09)60021-8
|
| 45 |
O. S. Shifrin, E. A. Poluektova, A. V. Korolev, T. I. Semenova, M. V. Shein, G. N. Leksikova, O. A. Tokareva, O. E. Davydova, P. S. Andreev, S. E. Katorkin, A. A. Chernov, A. V. Zhuravlev, O. S. Sek, A. A. Kopina, N. Yu. Samokhina, Yu. V. Gorozhankina, M. F. Samigullin, V. S. Groshilin, E. N. Borisova, T. A. Petrova, I. Yu. Pirogova, S. V. Mednikov, N. V. Smagin, A. S. Sarsenbaeva, N. V. Smirnova, L. G. Kirsanova, N. M. Malyutina, M. A. Smirnova, E. N. Shleikova, V. T. Ivashkin. Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(1): 14 doi: 10.22416/1382-4376-2020-30-1-14-25
|
| 46 |
Iain O’Neill. A Worldwide Perspective on Diagnosis and Management of Diverticular Disease: Understanding Similarities and Differences. EMJ Gastroenterology 2018; : 40 doi: 10.33590/emjgastroenterol/10311869
|
| 47 |
Maurizio Koch, Alberto Enrico Maraolo, Giuseppe Natoli, Salvatore Corrao. Preventing acute diverticulitis. any roles for non-absorbable antibiotics? in search of evidence: a systematic review, meta-analysis, and trial sequential analysis. Frontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1170271
|
| 48 |
Adi Lahat, Herma H Fidder, Shomron Ben-Horin. Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort. Therapeutic Advances in Gastroenterology 2020; 13: 175628482091321 doi: 10.1177/1756284820913210
|
| 49 |
Mona Rezapour, Neil Stollman. Management of Diverticulosis. Current Treatment Options in Gastroenterology 2021; 19(1): 14 doi: 10.1007/s11938-020-00329-4
|
| 50 |
Giovanni Latella, Carmelo Scarpignato. Rifaximin in the management of colonic diverticular disease. Expert Review of Gastroenterology & Hepatology 2009; 3(6): 585 doi: 10.1586/egh.09.63
|
| 51 |
|
| 52 |
Angel Lanas, Julio Ponce, Angelo Bignamini, Fermín Mearin. One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: A proof-of-concept study. Digestive and Liver Disease 2013; 45(2): 104 doi: 10.1016/j.dld.2012.09.006
|
| 53 |
Stéphane M. Schneider, Sarah Giudicelli. Probiotiques Et Autres Pathologies Digestives : Perspectives. Cahiers de Nutrition et de Diététique 2007; 42: 60 doi: 10.1016/S0007-9960(07)91323-1
|
| 54 |
Carla J. Gargallo Puyuelo, Federico Sopeña, Angel Lanas Arbeloa. Colonic diverticular disease. Treatment and prevention. Gastroenterología y Hepatología 2015; 38(10): 590 doi: 10.1016/j.gastrohep.2015.03.010
|
| 55 |
T. Pohle, W. Domschke, C. Reißfelder, B. Schmied, M.W. Büchler. Therapie-Handbuch Grundwerk inkl 6. Lfg.. 2015; : 1 doi: 10.1016/B978-3-437-22107-1.50179-5
|
| 56 |
Anna Piccin, Marco Gulotta, Stefano di Bella, Paola Martingano, Lory Saveria Crocè, Mauro Giuffrè. Diverticular Disease and Rifaximin: An Evidence-Based Review. Antibiotics 2023; 12(3): 443 doi: 10.3390/antibiotics12030443
|
| 57 |
Antonio Tursi. Preventing recurrent acute diverticulitis with pharmacological therapies. Therapeutic Advances in Chronic Disease 2013; 4(6): 277 doi: 10.1177/2040622313498809
|
| 58 |
Rosario Cuomo, Giovanni Barbara, Bruno Annibale. Rifaximin and diverticular disease: Position paper of the Italian Society of Gastroenterology (SIGE). Digestive and Liver Disease 2017; 49(6): 595 doi: 10.1016/j.dld.2017.01.164
|
| 59 |
Federico Sopeña, Angel Lanas. Management of colonic diverticular disease with poorly absorbed antibiotics and other therapies. Therapeutic Advances in Gastroenterology 2011; 4(6): 365 doi: 10.1177/1756283X11412820
|
| 60 |
Giovanni Marasco, Francesco Buttitta, Cesare Cremon, Maria Raffaella Barbaro, Vincenzo Stanghellini, Giovanni Barbara. The role of microbiota and its modulation in colonic diverticular disease. Neurogastroenterology & Motility 2023; 35(12) doi: 10.1111/nmo.14615
|
| 61 |
M. Bianchi, V. Festa, A. Moretti, A. Ciaco, M. Mangone, V. Tornatore, A. Dezi, R. Luchetti, B. De Pascalis, C. Papi, M. Koch. Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease. Alimentary Pharmacology & Therapeutics 2011; 33(8): 902 doi: 10.1111/j.1365-2036.2011.04606.x
|
| 62 |
Rosario Cuomo, Giovanni Barbara, Fabio Pace, Vito Annese, Gabrio Bassotti, Gian Andrea Binda, Tino Casetti, Antonio Colecchia, Davide Festi, Roberto Fiocca, Andrea Laghi, Giovanni Maconi, Riccardo Nascimbeni, Carmelo Scarpignato, Vincenzo Villanacci, Bruno Annibale. Italian consensus conference for colonic diverticulosis and diverticular disease. United European Gastroenterology Journal 2014; 2(5): 413 doi: 10.1177/2050640614547068
|
| 63 |
Akira Mizuki, Masayuki Tatemichi, Atsushi Nakazawa, Nobuhiro Tsukada, Hiroshi Nagata, Yoshikazu Kinoshita. Effects of Burdock tea on recurrence of colonic diverticulitis and diverticular bleeding: An open-labelled randomized clinical trial. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-43236-0
|
| 64 |
Keta K. Vaidya, Martin H. Floch. Diverticular Disease: Paradigm Shifts in Pathogenesis and Treatment. Current Treatment Options in Gastroenterology 2015; 13(1): 143 doi: 10.1007/s11938-014-0045-4
|
| 65 |
G. A. Binda, R. Cuomo, A. Laghi, R. Nascimbeni, A. Serventi, D. Bellini, P. Gervaz, B. Annibale. Practice parameters for the treatment of colonic diverticular disease: Italian Society of Colon and Rectal Surgery (SICCR) guidelines. Techniques in Coloproctology 2015; 19(10): 615 doi: 10.1007/s10151-015-1370-x
|
| 66 |
Francesco Di Mario, Chiara Miraglia, Ginevra Cambiè, Alessandra Violi, Antonio Nouvenne, Marilisa Franceschi, Giovanni Brandimarte, Walter Elisei, Marcello Picchio, Antonio Tursi. Long-term efficacy of rifaximin to manage the symptomatic uncomplicated diverticular disease of the colon. Journal of Investigative Medicine 2019; 67(4): 767 doi: 10.1136/jim-2018-000901
|
| 67 |
Jeannette Y. Wick. Diverticular Disease: Eat Your Fiber!. The Consultant Pharmacist 2012; 27(9): 613 doi: 10.4140/TCP.n.2012.613
|
| 68 |
Lino Polese, Alice Bressan, Edoardo Savarino, Massimo Vecchiato, Angelo Turoldo, Annachiara Frigo, Giacomo Carlo Sturniolo, Nicolò De Manzini, Roberto Petri, Stefano Merigliano. Quality of life after laparoscopic sigmoid resection for uncomplicated diverticular disease. International Journal of Colorectal Disease 2018; 33(5): 513 doi: 10.1007/s00384-018-3005-y
|
| 69 |
Alba Rocco, Debora Compare, Flora Caruso, Gerardo Nardone. Treatment Options for Uncomplicated Diverticular Disease of the Colon. Journal of Clinical Gastroenterology 2009; 43(9): 803 doi: 10.1097/MCG.0b013e3181b3ab2e
|
| 70 |
Jeffrey M. Fox, Neil H. Stollman. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010; : 2073 doi: 10.1016/B978-1-4160-6189-2.00117-7
|
| 71 |
Francesca Romana Ponziani, Viviana Gerardi, Silvia Pecere, Francesca D’Aversa, Loris Lopetuso, Maria Assunta Zocco, Maurizio Pompili, Antonio Gasbarrini. Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications. World Journal of Gastroenterology 2015; 21(43): 12322-12333 doi: 10.3748/wjg.v21.i43.12322
|
| 72 |
Jason Hemming, Martin Floch. Features and Management of Colonic Diverticular Disease. Current Gastroenterology Reports 2010; 12(5): 399 doi: 10.1007/s11894-010-0126-z
|
| 73 |
Giacomo Calini, Mohamed A Abd El Aziz, Lucia Paolini, Solafah Abdalla, Matteo Rottoli, Giulio Mari, David W Larson. Symptomatic Uncomplicated Diverticular Disease (SUDD): Practical Guidance and Challenges for Clinical Management. Clinical and Experimental Gastroenterology 2023; : 29 doi: 10.2147/CEG.S340929
|
| 74 |
Alberto Lué, Viviana Laredo, Angel Lanas. Medical Treatment of Diverticular Disease. Journal of Clinical Gastroenterology 2016; 50(Supplement 1): S57 doi: 10.1097/MCG.0000000000000593
|
| 75 |
Antonietta Gerarda Gravina, Raffaele Pellegrino, Salvatore Auletta, Giovanna Palladino, Giovanni Brandimarte, Rossella D’Onofrio, Giusi Arboretto, Giuseppe Imperio, Andrea Ventura, Marina Cipullo, Marco Romano, Alessandro Federico. <i>Hericium erinaceus</i>, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases. World Journal of Gastroenterology 2023; 29(20): 3048-3065 doi: 10.3748/wjg.v29.i20.3048
|
| 76 |
Francesca Romana Ponziani, Franco Scaldaferri, Valentina Petito, Francesco Paroni Sterbini, Silvia Pecere, Loris R. Lopetuso, Alessandra Palladini, Viviana Gerardi, Luca Masucci, Maurizio Pompili, Giovanni Cammarota, Maurizio Sanguinetti, Antonio Gasbarrini. The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin. Digestive Diseases 2016; 34(3): 269 doi: 10.1159/000443361
|